Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.
A new Labcorp technique for early detection of Alzheimer’s disease for adults ages 50 and older has become available nationwide, the Burlington company announced last week. The Food and Drug ...
Verywell Health on MSN
How to Find Out Your Blood Type Easily and Why It Matters for Your Health
Most people don't know their blood type, but there are a few ways you can find out. Here's what experts suggest.
Labcorp Holdings (LH) has been on the radar lately, and not necessarily because of a major event shaking the market. Sometimes even subtle moves are enough to make investors take note. Even without a ...
In June 2025, updated versions of several Organization for Economic Co-operation and Development (OECD) Test Guidelines were published. This has impacted the study design of three key Test Guidelines ...
Please provide your email address to receive an email when new articles are posted on . Labcorp said its national network can ease burdens of access to testing for Alzheimer’s disease. Blood-based ...
While advanced medical technology can go a long way toward supporting the military, so can supplies, materials and equipment that are commonly used in medical settings. Small businesses that provide ...
MCA scores help officials know if their school is making progress and help the state identify which schools need support, said Michael Rodriguez, dean of the University of Minnesota’s College of ...
SpaceX plans to conduct the 10th flight test of its Starship spacecraft Sunday, Aug. 24. SpaceX will host a livestream of the flight test that will begin about 30 minutes before liftoff. SpaceX has a ...
Fueled by federal funding, JHU researchers and scientists seek investors to back their ideas to bring discoveries to the market ...
TipRanks on MSN
Labcorp price target raised to $290 from $275 at Barclays
Barclays raised the firm’s price target on Labcorp (LH) to $290 from $275 and keeps an Equal Weight rating on the shares as part of a Q3 preview ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results